Clinical Trials
2 trialsNCT06135896 2025-06-18
Dulastin
National Cancer Center, Korea
Phase 2 Recruiting
NCT02035072 2017-07-21
Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer.
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Completed